Plazomicin Nitroso Impurity 1
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Plazomicin is a parenterally administered, broad spectrum aminoglycoside antibiotic typically used for moderate-to-severe urinary tract infections or pyelonephritis.Plazomicin Nitroso Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Plazomicin Nitroso Impurity 1 CAS NO:NA Chemically represented as (S)-4-amino-N-((1R,2S,3S,4R,5S)-5-amino-4-(((2S,3R)-3-amino-6-(((2-hydroxyethyl)amino)methyl)-3,4-dihydro-2H-pyran-2-yl)oxy)-2-(((2R,3R,4R,5R)-3,5-dihydroxy-5-methyl-4-(methyl(nitroso)amino)tetrahydro-2H-pyran-2-yl)oxy)-3-hydroxycyclohexyl)-2-hydroxybutanamide. Synchemia is the leading manufacturing and exporter of Plazomicin Nitroso Impurity 1. We supply Plazomicin Nitroso Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N014598 |
| CAS No | NA |
| Mol.F. | C13H15N3O |
| Mol.Wt. | 229.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014599 |
| CAS No | 2817316-41-7 |
| Mol.F. | C6H17N5O |
| Mol.Wt. | 175.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014600 |
| CAS No | 278783-22-5 |
| Mol.F. | C13H15N3O3 |
| Mol.Wt. | 261.3 g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-N014601 |
| CAS No | NA |
| Mol.F. | C16H15ClN4O4S |
| Mol.Wt. | 394.8 |
| INV STATUS | In Stock |
| CAT No | SRC-N014602 |
| CAS No | NA |
| Mol.F. | C6H12N2O5 |
| Mol.Wt. | 192.2 g/mol |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N014603 |
| CAS No | NA |
| Mol.F. | C23H27F2N7O5S |
| Mol.Wt. | 551.6 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014604 |
| CAS No | NA |
| Mol.F. | C14H11ClN2O3 |
| Mol.Wt. | 290.7 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014605 |
| CAS No | NA |
| Mol.F. | C15H17N5O6 |
| Mol.Wt. | 363.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014606 |
| CAS No | NA |
| Mol.F. | C14H8Cl3N3O2S |
| Mol.Wt. | 388.6 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014607 |
| CAS No | NA |
| Mol.F. | C16H23N3O3 |
| Mol.Wt. | 305.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014608 |
| CAS No | NA |
| Mol.F. | C6H16N6O2 |
| Mol.Wt. | 204.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014609 |
| CAS No | 120314-14-9 |
| Mol.F. | C10H10N2O2 |
| Mol.Wt. | 190.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014610 |
| CAS No | 2703749-87-3 |
| Mol.F. | C14H13N3O |
| Mol.Wt. | 239.3 g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-N014611 |
| CAS No | NA |
| Mol.F. | C5H4N6O2 |
| Mol.Wt. | 180.13 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014612 |
| CAS No | NA |
| Mol.F. | C30H28ClN7O4 |
| Mol.Wt. | 586 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014613 |
| CAS No | NA |
| Mol.F. | C14H21N7O6 |
| Mol.Wt. | 383.4 |
| INV STATUS | CUSTOM SYNTHESIS |